Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Key Takeaway: Mirum Pharmaceuticals has reported inducement grants in accordance with Nasdaq Listing Rule 5635(c)(4). The details of these grants were not specified in the announcement. This move is part of the company's compliance with regulatory requirements.